Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Redman

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcomaF A Momin, M Zalupski, L K Heilbrun, et al.
Cancer|June 1, 1993
A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanomaL E Flaherty, W Robinson, B G Redman, et al.
Urology|September 25, 1997
A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancerK J Pienta, B G Redman, R Bandekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancerB G Redman, L Flaherty, T H Chou, et al.
Cancer|June 1, 1990
A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanomaL E Flaherty, B G Redman, G G Chabot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end pointE J Small, D Lew, B G Redman, et al.
Cancer Research|February 24, 2001
Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agentsK A Candido, K Shimizu, J C McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I studyG J Brewer, R D Dick, D K Grover, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcomaF A Momin, M Zalupski, L K Heilbrun, et al.
Cancer|June 1, 1993
A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanomaL E Flaherty, W Robinson, B G Redman, et al.
Urology|September 25, 1997
A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancerK J Pienta, B G Redman, R Bandekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
A phase I trial of recombinant interleukin-2 combined with recombinant interferon-gamma in patients with cancerB G Redman, L Flaherty, T H Chou, et al.
Cancer|June 1, 1990
A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanomaL E Flaherty, B G Redman, G G Chabot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end pointE J Small, D Lew, B G Redman, et al.
Cancer Research|February 24, 2001
Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agentsK A Candido, K Shimizu, J C McLaughlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I studyG J Brewer, R D Dick, D K Grover, et al.
Pageof 4